Department of Medical Oncology, Hospital AC Camargo, São Paulo, Brazil.
Fertil Steril. 2010 Jun;94(1):138-43. doi: 10.1016/j.fertnstert.2009.02.055. Epub 2009 Apr 1.
To investigate methods of fertility preservation in younger women exposed to adjuvant chemotherapy for breast cancer.
Systematic review of literature.
Academic Department of Medical Oncology.
PATIENT(S): Premenopausal women exposed to adjuvant chemotherapy for breast cancer.
MAIN OUTCOME MEASURE(S): Fertility preservation.
RESULT(S): Data for fertility preservation in this setting come from nonrandomized trials and observational studies. The main methods of fertility preservation are ovarian protection by gonadotropin-releasing hormone (GnRH) agonists, cryopreservation of embryos after in vitro fertilization, and preservation of operatively sampled ovarian tissue or eggs after stimulation and puncture. Ongoing trials are assessing the role of ovarian protection by GnRH agonists.
CONCLUSION(S): At present, there are no high-level, evidence-based recommendations for preservation of fertility or of ovarian function in women with breast cancer. This is an important issue for young breast cancer survivors, and further studies are needed. Moreover, the interplay between ovarian protection by GnRH agonists and the efficacy of adjuvant chemotherapy remains elusive.
探讨接受辅助化疗的年轻乳腺癌女性的生育力保存方法。
文献系统回顾。
医学肿瘤学学术部门。
接受辅助化疗的绝经前乳腺癌女性。
生育力保存。
该治疗环境下的生育力保存数据来自非随机试验和观察性研究。生育力保存的主要方法是促性腺激素释放激素(GnRH)激动剂的卵巢保护、体外受精后胚胎冷冻保存,以及刺激和穿刺后手术取样的卵巢组织或卵子的保存。正在进行的试验评估 GnRH 激动剂对卵巢保护的作用。
目前,对于乳腺癌女性的生育力或卵巢功能的保护,尚无高级别、基于证据的推荐意见。这是年轻乳腺癌幸存者的一个重要问题,需要进一步研究。此外,GnRH 激动剂的卵巢保护与辅助化疗的疗效之间的相互作用仍不清楚。